Cargando…

SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma

Intratumoral heterogeneity is a characteristic of glioblastomas that contain an intermixture of cell populations displaying different glioblastoma subtype gene expression signatures. Proportions of these populations change during tumor evolution, but the occurrence and regulation of glioblastoma sub...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Min, Goudarzi, Kaveh M., Abedi, Shiva, Pieber, Melanie, Sjöberg, Elin, Behnan, Jinan, Zhang, Xing-Mei, Harris, Robert A., Bartek, Jiri, Lindström, Mikael S., Nistér, Monica, Hägerstrand, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363098/ https://www.ncbi.nlm.nih.gov/pubmed/34021259 http://dx.doi.org/10.1038/s41388-021-01825-2

Ejemplares similares

Correction to: SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma
por: Guo, Min, et al.
Publicado: (2021)

NPM1 histone chaperone is upregulated in glioblastoma to promote cell survival and maintain nucleolar shape
por: Holmberg Olausson, Karl, et al.
Publicado: (2015)

Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile
por: Hägerstrand, Daniel, et al.
Publicado: (2011)

Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival
por: Majchrzak-Celińska, Aleksandra, et al.
Publicado: (2015)

Identification of functionally distinct and interacting cancer cell subpopulations from glioblastoma with intratumoral genetic heterogeneity
por: Guo, Min, et al.
Publicado: (2020)

Role of ribosomal protein mutations in tumor development (Review)
por: GOUDARZI, KAVEH M., et al.
Publicado: (2016)

Altered cytoskeletal status in the transition from proneural to mesenchymal glioblastoma subtypes
por: Keller, Maureen, et al.
Publicado: (2022)

Ultrasonic Surgical Aspirate is a Reliable Source For Culturing Glioblastoma Stem Cells
por: Behnan, Jinan, et al.
Publicado: (2016)

Silencing of Ribosomal Protein S9 Elicits a Multitude of Cellular Responses Inhibiting the Growth of Cancer Cells Subsequent to p53 Activation
por: Lindström, Mikael S., et al.
Publicado: (2010)

Expression and prognostic value of SFRP1 and β-catenin in patients with glioblastoma
por: CHANG, LIANG, et al.
Publicado: (2016)

Expression Levels and Localizations of DVL3 and sFRP3 in Glioblastoma
por: Kafka, Anja, et al.
Publicado: (2017)

Expanding the scope of candidate prognostic marker IGFBP2 in glioblastoma
por: Lindström, Mikael S.
Publicado: (2019)

Study of SFRP1 and SFRP2 methylation status in patients with de novo Acute Myeloblastic Leukemia
por: Ghasemi, Ali, et al.
Publicado: (2015)

DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients
por: Liu, Xinyan, et al.
Publicado: (2019)

The association between Annexin A2 and epithelial cell adhesion molecule in breast cancer cells
por: Al‐Qahtani, Saad Misfer, et al.
Publicado: (2021)

Targeting SOX2 as a Therapeutic Strategy in Glioblastoma
por: Garros-Regulez, Laura, et al.
Publicado: (2016)

The landscape of the mesenchymal signature in brain tumours
por: Behnan, Jinan, et al.
Publicado: (2019)

Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype
por: Wu, Yonghe, et al.
Publicado: (2020)

The role of dexamethasone in mediating the contradictory effects of Wnt antagonists SFRP2 and SFRP3 on human hair follicle growth
por: Hamida, Ons Ben, et al.
Publicado: (2023)

p53 -Dependent and -Independent Nucleolar Stress Responses
por: Olausson, Karl Holmberg, et al.
Publicado: (2012)

SFRP2 Is Associated with Increased Adiposity and VEGF Expression
por: Crowley, Rachel K., et al.
Publicado: (2016)

CRISPR/Cas9 Deletion of SOX2 Regulatory Region 2 (SRR2) Decreases SOX2 Malignant Activity in Glioblastoma
por: Saenz-Antoñanzas, Ander, et al.
Publicado: (2021)

Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward
por: Zisi, Asimina, et al.
Publicado: (2022)

Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma
por: Sremac, Maja, et al.
Publicado: (2021)

p53 at the crossroad of DNA replication and ribosome biogenesis stress pathways
por: Lindström, Mikael S., et al.
Publicado: (2022)

Oncogenic activity of SOX1 in glioblastoma
por: Garcia, Idoia, et al.
Publicado: (2017)

Novel Perspectives on p53 Function in Neural Stem Cells and Brain Tumors
por: Hede, Sanna-Maria, et al.
Publicado: (2011)

Neural network learning defines glioblastoma features to be of neural crest perivascular or radial glia lineages
por: Hu, Yizhou, et al.
Publicado: (2022)

sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
por: Kaur, Amanpreet, et al.
Publicado: (2016)

Dopamine signaling: target in glioblastoma
por: Bartek, Jiri, et al.
Publicado: (2014)

Hyperactivated Wnt-β-catenin signaling in the absence of sFRP1 and sFRP5 disrupts trophoblast differentiation through repression of Ascl2
por: Bao, Haili, et al.
Publicado: (2020)

EZH2 regulates sFRP4 expression without affecting the methylation of sFRP4 promoter DNA in colorectal cancer cell lines
por: Liu, Yuting, et al.
Publicado: (2020)

SFRP2 and Slug Contribute to Cellular Resistance to Apoptosis in Hypertrophic Scars
por: Chen, Liang, et al.
Publicado: (2012)

The defect of SFRP2 modulates an influx of extracellular calcium in B lymphocytes
por: Tokuda, Yuichi, et al.
Publicado: (2014)

Feasibility of Plasma-Methylated SFRP2 for Early Detection of Gastric Cancer
por: Miao, Jin, et al.
Publicado: (2020)

The Silencing of SFRP2 Expression in ESCC Is Due to Methylation of the Gene Promoter
por: Liu, Qian, et al.
Publicado: (2019)

Multiple Roles of sFRP2 in Cardiac Development and Cardiovascular Disease
por: Wu, Yu, et al.
Publicado: (2020)

Elevating SOX2 Levels Deleteriously Affects the Growth of Medulloblastoma and Glioblastoma Cells
por: Cox, Jesse L., et al.
Publicado: (2012)

Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma
por: Bhuvanalakshmi, Gurubharathi, et al.
Publicado: (2018)

LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma
por: Liu, Boyang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_220cs7p7t8d0toc0msojkrchn0